Cargando…
A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesis
Desmogleins (DSG) are a family of cadherin adhesion proteins that were first identified in desmosomes and provide cardiomyocytes and epithelial cells with the junctional stability to tolerate mechanical stress. However, one member of this family, DSG2, is emerging as a protein with additional biolog...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026727/ https://www.ncbi.nlm.nih.gov/pubmed/27338829 http://dx.doi.org/10.1007/s10456-016-9520-y |
_version_ | 1782454151132741632 |
---|---|
author | Ebert, Lisa M. Tan, Lih Y. Johan, M. Zahied Min, Kay Khine Myo Cockshell, Michaelia P. Parham, Kate A. Betterman, Kelly L. Szeto, Paceman Boyle, Samantha Silva, Lokugan Peng, Angela Zhang, YouFang Ruszkiewicz, Andrew Zannettino, Andrew C. W. Gronthos, Stan Koblar, Simon Harvey, Natasha L. Lopez, Angel F. Shackleton, Mark Bonder, Claudine S. |
author_facet | Ebert, Lisa M. Tan, Lih Y. Johan, M. Zahied Min, Kay Khine Myo Cockshell, Michaelia P. Parham, Kate A. Betterman, Kelly L. Szeto, Paceman Boyle, Samantha Silva, Lokugan Peng, Angela Zhang, YouFang Ruszkiewicz, Andrew Zannettino, Andrew C. W. Gronthos, Stan Koblar, Simon Harvey, Natasha L. Lopez, Angel F. Shackleton, Mark Bonder, Claudine S. |
author_sort | Ebert, Lisa M. |
collection | PubMed |
description | Desmogleins (DSG) are a family of cadherin adhesion proteins that were first identified in desmosomes and provide cardiomyocytes and epithelial cells with the junctional stability to tolerate mechanical stress. However, one member of this family, DSG2, is emerging as a protein with additional biological functions on a broader range of cells. Here we reveal that DSG2 is expressed by non-desmosome-forming human endothelial progenitor cells as well as their mature counterparts [endothelial cells (ECs)] in human tissue from healthy individuals and cancer patients. Analysis of normal blood and bone marrow showed that DSG2 is also expressed by CD34(+)CD45(dim) hematopoietic progenitor cells. An inability to detect other desmosomal components, i.e., DSG1, DSG3 and desmocollin (DSC)2/3, on these cells supports a solitary role for DSG2 outside of desmosomes. Functionally, we show that CD34(+)CD45(dim)DSG2(+) progenitor cells are multi-potent and pro-angiogenic in vitro. Using a ‘knockout-first’ approach, we generated a Dsg2 loss-of-function strain of mice (Dsg2(lo/lo)) and observed that, in response to reduced levels of Dsg2: (i) CD31(+) ECs in the pancreas are hypertrophic and exhibit altered morphology, (ii) bone marrow-derived endothelial colony formation is impaired, (iii) ex vivo vascular sprouting from aortic rings is reduced, and (iv) vessel formation in vitro and in vivo is attenuated. Finally, knockdown of DSG2 in a human bone marrow EC line reveals a reduction in an in vitro angiogenesis assay as well as relocalisation of actin and VE-cadherin away from the cell junctions, reduced cell–cell adhesion and increased invasive properties by these cells. In summary, we have identified DSG2 expression in distinct progenitor cell subpopulations and show that, independent from its classical function as a component of desmosomes, this cadherin also plays a critical role in the vasculature. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10456-016-9520-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5026727 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer Netherlands |
record_format | MEDLINE/PubMed |
spelling | pubmed-50267272016-10-07 A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesis Ebert, Lisa M. Tan, Lih Y. Johan, M. Zahied Min, Kay Khine Myo Cockshell, Michaelia P. Parham, Kate A. Betterman, Kelly L. Szeto, Paceman Boyle, Samantha Silva, Lokugan Peng, Angela Zhang, YouFang Ruszkiewicz, Andrew Zannettino, Andrew C. W. Gronthos, Stan Koblar, Simon Harvey, Natasha L. Lopez, Angel F. Shackleton, Mark Bonder, Claudine S. Angiogenesis Original Paper Desmogleins (DSG) are a family of cadherin adhesion proteins that were first identified in desmosomes and provide cardiomyocytes and epithelial cells with the junctional stability to tolerate mechanical stress. However, one member of this family, DSG2, is emerging as a protein with additional biological functions on a broader range of cells. Here we reveal that DSG2 is expressed by non-desmosome-forming human endothelial progenitor cells as well as their mature counterparts [endothelial cells (ECs)] in human tissue from healthy individuals and cancer patients. Analysis of normal blood and bone marrow showed that DSG2 is also expressed by CD34(+)CD45(dim) hematopoietic progenitor cells. An inability to detect other desmosomal components, i.e., DSG1, DSG3 and desmocollin (DSC)2/3, on these cells supports a solitary role for DSG2 outside of desmosomes. Functionally, we show that CD34(+)CD45(dim)DSG2(+) progenitor cells are multi-potent and pro-angiogenic in vitro. Using a ‘knockout-first’ approach, we generated a Dsg2 loss-of-function strain of mice (Dsg2(lo/lo)) and observed that, in response to reduced levels of Dsg2: (i) CD31(+) ECs in the pancreas are hypertrophic and exhibit altered morphology, (ii) bone marrow-derived endothelial colony formation is impaired, (iii) ex vivo vascular sprouting from aortic rings is reduced, and (iv) vessel formation in vitro and in vivo is attenuated. Finally, knockdown of DSG2 in a human bone marrow EC line reveals a reduction in an in vitro angiogenesis assay as well as relocalisation of actin and VE-cadherin away from the cell junctions, reduced cell–cell adhesion and increased invasive properties by these cells. In summary, we have identified DSG2 expression in distinct progenitor cell subpopulations and show that, independent from its classical function as a component of desmosomes, this cadherin also plays a critical role in the vasculature. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10456-016-9520-y) contains supplementary material, which is available to authorized users. Springer Netherlands 2016-06-23 2016 /pmc/articles/PMC5026727/ /pubmed/27338829 http://dx.doi.org/10.1007/s10456-016-9520-y Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Paper Ebert, Lisa M. Tan, Lih Y. Johan, M. Zahied Min, Kay Khine Myo Cockshell, Michaelia P. Parham, Kate A. Betterman, Kelly L. Szeto, Paceman Boyle, Samantha Silva, Lokugan Peng, Angela Zhang, YouFang Ruszkiewicz, Andrew Zannettino, Andrew C. W. Gronthos, Stan Koblar, Simon Harvey, Natasha L. Lopez, Angel F. Shackleton, Mark Bonder, Claudine S. A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesis |
title | A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesis |
title_full | A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesis |
title_fullStr | A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesis |
title_full_unstemmed | A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesis |
title_short | A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesis |
title_sort | non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesis |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026727/ https://www.ncbi.nlm.nih.gov/pubmed/27338829 http://dx.doi.org/10.1007/s10456-016-9520-y |
work_keys_str_mv | AT ebertlisam anoncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT tanlihy anoncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT johanmzahied anoncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT minkaykhinemyo anoncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT cockshellmichaeliap anoncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT parhamkatea anoncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT bettermankellyl anoncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT szetopaceman anoncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT boylesamantha anoncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT silvalokugan anoncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT pengangela anoncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT zhangyoufang anoncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT ruszkiewiczandrew anoncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT zannettinoandrewcw anoncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT gronthosstan anoncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT koblarsimon anoncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT harveynatashal anoncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT lopezangelf anoncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT shackletonmark anoncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT bonderclaudines anoncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT ebertlisam noncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT tanlihy noncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT johanmzahied noncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT minkaykhinemyo noncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT cockshellmichaeliap noncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT parhamkatea noncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT bettermankellyl noncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT szetopaceman noncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT boylesamantha noncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT silvalokugan noncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT pengangela noncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT zhangyoufang noncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT ruszkiewiczandrew noncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT zannettinoandrewcw noncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT gronthosstan noncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT koblarsimon noncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT harveynatashal noncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT lopezangelf noncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT shackletonmark noncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis AT bonderclaudines noncanonicalrolefordesmoglein2inendothelialcellsimplicationsforneoangiogenesis |